Serine/threonine protein phosphatases in apoptosis

Apoptosis, Cell Signaling, and Human Diseases

Volumn 2, Issue , 2007, Pages 151-166

  Gausdal, Gro ^a   Krakstad, Camilla ^a   Herfindal, Lars ^a   Døskeland, Stein Ove ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

calmodulin dependent protein kinase; Cell death; microcystin; myosin light chain; okadaic acid; PP2A; protein phosphorylation

Indexed keywords

EID: 80955179831     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-199-4_7     Document Type: Chapter

References (129)

1. Gjertsen BT, Doskeland SO. Protein phosphorylation in apoptosis. Biochim Biophys Acta 1995;1269:187-199.
2. Lavin MF, Watters D, Song Q. Role of protein kinase activity in apoptosis. Experientia 1996;52:979-994.
3. Zwick E, Bange J, Ullrich A. Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr Relat Cancer 2001;8:161-173.
4. Burma S, Chen DJ. Role of DNA-PK in the cellular response to DNA double-strand breaks. DNA Repair (Amst) 2004;3:909-918.
5. Chang F, Steelman LS, Shelton JG, et al. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). Int J Oncol 2003;22:469-480.
6. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 2003;22:8983-8998.
7. Bjornsti MA, Houghton PJ. Lost in translation: dysregulation of cap-dependent translation and cancer. Cancer Cell 2004;5:519-523.
8. Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase c delta. Apoptosis 2003;8:19-27.
9. Webb PR, Wang KQ, Scheel-Toellner D, Pongracz J, Salmon M, Lord JM. Regulation of neutrophil apoptosis: a role for protein kinase C and phosphatidylinositol-3-kinase. Apoptosis 2000;5:451-458.
10. Hanks SK, Ryzhova L, Shin NY, Brabek J. Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci 2003; 8:d982-d996.
11. Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004;23:2838-2849.
12. Cohen PT. Protein phosphatase 1-targeted in many directions. J Cell Sci 2002;115: 241-256.
13. Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem 1989; 58:453-508.
14. Millward TA, Zolnierowicz S, Hemmings BA. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999;24:186-191.
15. Ceulemans H, Bollen M. Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol Rev 2004;84:1-39.
16. Van Hoof C, Goris J. Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question. Biochim Biophys Acta 2003;1640:97-104.
17. Van Hoof C, Goris J. PP2A fulfills its promises as tumor suppressor: which subunits are important? Cancer Cell 2004;5:105-106.
18. Gehringer MM. Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response. FEBS Lett 2004;557:1-8.
19. Mumby MC, Walter G Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev 1993;73:673-699.
20. Klumpp S, Krieglstein J. Serine/threonine protein phosphatases in apoptosis. Curr Opin Pharmacol 2002;2:458-462.
21. Garcia A, Cayla X, Guergnon J, et al. Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis. Biochimie 2003;85:721-726.
22. Suganuma M, Fujiki H, Suguri H, et al. Okadaic acid: an additional non-phorbol-12-tetra-decanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 1988;85:1768-1771.
23. Pallas DC, Shahrik LK, Martin BL, et al. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 1990;60:167-176.
24. Yang SI, Lickteig RL, Estes R, Rundell K, Walter G, Mumby MC. Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol Cell Biol 1991;11:1988-1995.
25. Scheidtmann KH, Mumby MC, Rundell K, Walter G. Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol Cell Biol 1991;11:1996-2003.
26. Li X, Scuderi A, Letsou A, Virshup DM. B56-associated protein phosphatase 2A is required for survival and protects from apoptosis in Drosophila melanogaster. Mol Cell Biol 2002;22:3674-3684.
27. Silverstein AM, Barrow CA, Davis AJ, Mumby MC. Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits. Proc Natl Acad Sci USA 2002;99:4221-4226.
28. Gjertsen BT, Cressey LI, Ruchaud S, Houge G, Lanotte M, Døskeland SO. Multiple apop-totic death types triggered through activation of separate pathways by cAMP and inhibitors of protein phosphatases in one (IPC leukemia) cell line. J Cell Sci 1994;107:3363-3377.
29. Cross T, Griffiths G, Deacon E, et al. PKC-delta is an apoptotic lamin kinase. Oncogene 2000;19:2331-2337.
30. van de Water B, Tijdens IB, Verbrugge A, et al. Cleavage of the actin-capping protein alpha-adducin at Asp-Asp-Ser-Asp633-Ala by caspase-3 is preceded by its phosphorylation on serine 726 in cisplatin-induced apoptosis of renal epithelial cells. J Biol Chem 2000;275:25, 805-25, 813.
31. Fladmark KE, Brustugun OT, Hovland R, et al. Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors. Cell Death Differ 1999;6:1099-1108.
32. Mills JC, Stone NL, Erhardt J, Pittman RN. Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation. J Cell Biol 1998;140:627-636.
33. Edelman AM, Lin WH, Osterhout DJ, Bennett MK, Kennedy MB, Krebs EG. Phosphorylation of smooth muscle myosin by type II Ca2+/calmodulin-dependent protein kinase. Mol Cell Biochem 1990;97:87-98.
34. Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996;271:20, 246-20, 249.
35. Ikebe M, Stepinska M, Kemp BE, Means AR, Hartshorne DJ. Proteolysis of smooth muscle myosin light chain kinase. Formation of inactive and calmodulin-independent fragments. J Biol Chem 1987;262:13, 828-13, 834.
36. Komatsu S, Hosoya H. Phosphorylation by MAPKAP kinase 2 activates Mg(2+)-ATPase activity of myosin II. Biochem Biophys Res Commun 1996;223:741-745.
37. Van Eyk JE, Arrell DK, Foster DB, et al. Different molecular mechanisms for Rho family GTPase-dependent, Ca2+-independent contraction of smooth muscle. J Biol Chem 1998; 273:23, 433-23, 439.
38. Niiro N, Ikebe M. Zipper-interacting protein kinase induces Ca(2+)-free smooth muscle contraction via myosin light chain phosphorylation. J Biol Chem 2001;276:29, 567-29, 574.
39. Endo A, Surks HK, Mochizuki S, Mochizuki N, Mendelsohn ME. Identification and characterization of zipper-interacting protein kinase as the unique vascular smooth muscle myosin phosphatase-associated kinase. J Biol Chem 2004;279:42, 055-42, 061.
40. Graves PR, Winkfield KM, Haystead TA. Regulation of zipper-interacting protein kinase activity in vitro and in vivo by multisite phosphorylation. J Biol Chem 2005;280:9363-9374.
41. Shani G, Marash L, Gozuacik D, et al. Death-associated protein kinase phosphorylates ZIP kinase, forming a unique kinase hierarchy to activate its cell death functions. Mol Cell Biol 2004;24:8611-8626.
42. Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282:1318-1321.
43. Martins LM, Kottke TJ, Kaufmann SH, Earnshaw WC. Phosphorylated forms of activated caspases are present in cytosol from HL-60 cells during etoposide-induced apoptosis. Blood 1998;92:3042-3049.
44. Alvarado-Kristensson M, Melander F, Leandersson K, Ronnstrand L, Wernstedt C, Andersson T. p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils. J Exp Med 2004;199:449-458.
45. O'Connor DS, Grossman D, Plescia J, et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 2000;97:13, 103-13, 107.
46. Dan HC, Sun M, Kaneko S, et al. Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 2004;279:5405-5412.
47. Ku NO, Omary MB. Effect of mutation and phosphorylation of type I keratins on their caspase-mediated degradation. J Biol Chem 2001;276:26, 792-26, 798.
48. Desagher S, Osen-Sand A, Montessuit S, et al. Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cell 2001;8:601-611.
49. Pinna LA, Donella-Deana A. Phosphorylated synthetic peptides as tools for studying protein phosphatases. Biochim Biophys Acta 1994;1222:415-431.
50. Tzivion G, Shen YH, Zhu J. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 2001;20:6331-6338.
51. Wang HG, Reed JC. Bc1-2, Raf-1 and mitochondrial regulation of apoptosis. Biofactors 1998;8:13-16.
52. Soane L, Cho HJ, Niculescu F, Rus H, Shin ML. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. J Immunol 2001;167:2305-2311.
53. Wang HG, Pathan N, Ethell IM, et al. Ca2+-induced apoptosis through calcineurin dephos-phorylation of BAD. Science 1999;284:339-343.
54. Klumpp S, Selke D, Krieglstein J. Protein phosphatase type 2C dephosphorylates BAD. Neurochem Int 2003;42:555-560.
55. Chiang CW, Kanies C, Kim KW, et al. Protein phosphatase 2A dephosphorylation of phos-phoserine 112 plays the gatekeeper role for BAD-mediated apoptosis. Mol Cell Biol 2003; 23:6350-6362.
56. Subramanian RR, Zhang H, Wang H, Ichijo H, Miyashita T, Fu H. Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. Exp Cell Res 2004;294:581-591.
57. Yellaturu CR, Bhanoori M, Neeli I, Rao GN. N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A. J Biol Chem 2002;277:40, 148-40, 155.
58. Burgering BM, Medema RH. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol 2003;73:689-701.
59. Yeh PY, Yeh KH, Chuang SE, Song YC, Cheng AL. Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation. J Biol Chem 2004;279:26, 143-26, 148.
60. Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 2001;268:2764-2772.
61. Ou YH, Chung PH, Sun TP, Shieh SY p53 C-Terminal Phosphorylation by CHK1 and CHK2 Participates in the Regulation of DNA-Damage-induced C-Terminal Acetylation. Mol Biol Cell 2005;16:1684-1695.
62. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998;20:709-726.
63. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 1999;286: 2358-2361.
64. Shieh PB, Hu SC, Bobb K, Timmusk T, Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 1998;20:727-740.
65. Nishihara H, Hwang M, Kizaka-Kondoh S, Eckmann L, Insel PA. Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1/2 and p38 MAPK. J Biol Chem 2004;279:26, 176-26, 183.
66. Ruchaud S, Seite P, Foulkes NS, Sassone-Corsi P, Lanotte M. The transcriptional repressor ICER and cAMP-induced programmed cell death. Oncogene 1997;15:827-836.
67. Lanotte M, Riviere JB, Hermouet S, et al. Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate-kinase I in a myeloid leukemia cell line. J Cell Physiol 1991;146:73-80.
68. Zandi E, Karin M. Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex. Mol Cell Biol 1999;19:4547-4551.
69. Carballo M, Marquez G, Conde M, et al. Characterization of calcineurin in human neutrophils. Inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-kappaB DNA binding. J Biol Chem 1999;274:93-100.
70. Miskolci V, Castro-Alcaraz S, Nguyen P, Vancura A, Davidson D, Vancurova I. Okadaic acid induces sustained activation of NFkappaB and degradation of the nuclear IkappaBalpha in human neutrophils. Arch Biochem Biophys 2003;417:44-52.
71. Alberts AS, Montminy M, Shenolikar S, Feramisco JR. Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts. Mol Cell Biol 1994;14:4398-4407.
72. Wadzinski BE, Wheat WH, Jaspers S, et al. Nuclear protein phosphatase 2A dephosphory-lates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol Cell Biol 1993;13:2822-2834.
73. Shi Y, Venkataraman SL, Dodson GE, Mabb AM, LeBlanc S, Tibbetts RS. Direct regulation of CREB transcriptional activity by ATM in response to genotoxic stress. Proc Natl Acad Sci USA 2004;101:5898-5903.
74. Leslie NR, Downes CP PTEN function: how normal cells control it and tumour cells lose it. Biochem J 2004;382:1-11.
75. Zolnierowicz S, Bollen M. Protein phosphorylation and protein phosphatases. De Panne, Belgium, September 19-24, 1999. Embo J 2000;19:483-488.
76. Ofek P, Ben-Meir D, Kariv-Inbal Z, Oren M, Lavi S. Cell cycle regulation and p53 activation by protein phosphatase 2C alpha. J Biol Chem 2003;278:14, 299-14, 305.
77. Cardenas ME, Sanfridson A, Cutler NS, Heitman J. Signal-transduction cascades as targets for therapeutic intervention by natural products. Trends Biotechnol 1998;16:427-433.
78. Lotem J, Kama R, Sachs L. Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin. Proc Natl Acad Sci USA 1999; 96:12, 016-12, 020.
79. Bueno OF, Lips DJ, Kaiser RA, et al. Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction. Circ Res 2004;94:91-99.
80. Kalivendi SV, Konorev EA, Cunningham S, Joseph J, Kalyanaraman B. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem J 2005;389:527-539.
81. Mukerjee N, McGinnis KM, Gnegy ME, Wang KK. Caspase-mediated calcineurin activation contributes to IL-2 release during T cell activation. Biochem Biophys Res Commun 2001; 285:1192-1199.
82. Nickels JT, Broach JR. A ceramide-activated protein phosphatase mediates ceramide-induced G1 arrest of Saccharomyces cerevisiae. Genes Dev 1996;10:382-394.
83. Silverstein AM, Galigniana MD, Chen MS, Owens-Grillo JK, Chinkers M, Pratt WB. Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin. J Biol Chem 1997;272:16, 224-16, 230.
84. Chen MX, McPartlin AE, Brown L, Chen YH, Barker HM, Cohen PT. A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus. Embo J 1994;13:4278-4290.
85. Chinkers M. Protein phosphatase 5 in signal transduction. Trends Endocrinol Metab 2001; 12:28-32.
86. Morita K, Saitoh M, Tobiume K, et al. Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. Embo J 2001;20:6028-6036.
87. Zhou G, Golden T, Aragon IV, Honkanen RE. Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade. J Biol Chem 2004;279:46, 595-46, 605.
88. Huang S, Shu L, Easton J, et al. Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity. J Biol Chem 2004;279:36, 490-36, 496.
89. Wechsler T, Chen BP, Harper R, et al. DNA-PKcs function regulated specifically by protein phosphatase 5. Proc Natl Acad Sci USA 2004;101:1247-1252.
90. Brewis ND, Cohen PT. Protein phosphatase X has been highly conserved during mammalian evolution. Biochim Biophys Acta 1992;1171:231-233.
91. Zhou G, Boomer JS, Tan TH. Protein phosphatase 4 is a positive regulator of hematopoietic progenitor kinase 1. J Biol Chem 2004;279:49, 551-46, 561.
92. Mourtada-Maarabouni M, Kirkham L, Jenkins B, et al. Functional expression cloning reveals proapoptotic role for protein phosphatase 4. Cell Death Differ 2003;10:1016-1024.
93. Zhou G, Mihindukulasuriya KA, MacCorkle-Chosnek RA, et al. Protein phosphatase 4 is involved in tumor necrosis factor-alpha-induced activation of c-Jun N-terminal kinase. J Biol Chem 2002;277:6391-6398.
94. Yang J, Fan GH, Wadzinski BE, Sakurai H, Richmond A. Protein phosphatase 2A interacts with and directly dephosphorylates RelA. J Biol Chem 2001;276:47, 828-47, 833.
95. Ward C, Walker A, Dransfield I, Haslett C, Rossi AG. Regulation of granulocyte apoptosis by NF-kappaB. Biochem Soc Trans 2004;32:465-467.
96. Cohen PT. Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem Sci 1997;22:245-251
97. Goldberg Y Protein phosphatase 2A: who shall regulate the regulator? Biochem Pharmacol 1999;57:321-328.
98. Sontag E. Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell Signal 2001; 13:7-16.
99. Li M, Makkinje A, Damuni Z. The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 1996;271:11, 059-11, 062.
100. Tamura Y, Simizu S, Osada H. The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria. FEBS Lett 2004;569:249-255.
101. Santoro MF, Annand RR, Robertson MM, et al. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J Biol Chem 1998;273:13, 119-13, 128.
102. Harmala-Brasken AS, Mikhailov A, Soderstrom TS, et al. Type-2A protein phosphatase activity is required to maintain death receptor responsiveness. Oncogene 2003;22:7677-7686.
103. Alvarado-Kristensson M, Andersson T Protein phosphatase 2A regulates apoptosis in neutrophils by dephosphorylating both p38 MAPK and its substrate caspase 3. J Biol Chem 2005;280:6238-6244.
104. Bøe R, Gjertsen BT, Vintermyr OK, Houge G, Lanotte M, Døskeland SO. The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp Cell Res 1991;195:237-246.
105. Fladmark KE, Brustugun OT, Mellgren G, et al. Ca2+/calmodulin-dependent protein kinase II is required for microcystin-induced apoptosis. J Biol Chem 2002;277:2804-2811.
106. Shtrichman R, Sharf R, Barr H, Dobner T, Kleinberger T. Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A. Proc Natl Acad Sci USA 1999;96:10, 080-10, 085.
107. Strack S, Cribbs JT, Gomez L. Critical role for protein phosphatase 2A heterotrimers in mammalian cell survival. J Biol Chem 2004;279:47, 732-47, 739.
108. Ayllon V, Cayla X, Garcia A, Fleischer A, Rebollo A. The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to Bad. Eur J Immunol 2002;32:1847-1855.
109. Chalfant CE, Rathman K, Pinkerman RL, et al. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J Biol Chem 2002;277:12, 587-12, 595.
110. Fujiki H, Suganuma M. Unique features of the okadaic acid activity class of tumor promoters. J Cancer Res Clin Oncol 1999;125:150-155.
111. Connor JH, Kleeman T, Barik S, Honkanen RE, Shenolikar S. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors. The Journal of Biological Chemistry 1999;274:22, 366-22, 372.
112. Dawson JF, Holmes CF Molecular mechanisms underlying inhibition of protein phosphatases by marine toxins. Front Biosci 1999;4:646-658.
113. Holmes CF, Maynes JT, Perreault KR, Dawson JF, James MN. Molecular enzymology underlying regulation of protein phosphatase-1 by natural toxins. Current Medicinal Chemistry 2002;9:1981-1989.
114. Mitsuhashi S, Matsuura N, Ubukata M, Oikawa H, Shima H, Kikuchi K. Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1. Biochem Biophys Res Commun 2001;287:328-331.
115. Walsh AH, Cheng A, Honkanen RE. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. FEBS Letters 1997;416:230-234.
116. Runnegar MT, Gerdes RG, Falconer IR. The uptake of the cyanobacterial hepatotoxin microcystin by isolated rat hepatocytes. Toxicon 1991;29:43-51.
117. Eriksson JE, Gronberg L, Nygard S, Slotte JP, Meriluoto JA. Hepatocellular uptake of 3H-dihydromicrocystin-LR, a cyclic peptide toxin. Biochim Biophys Acta 1990;1025:60-66.
118. Schulman H, Hanson PI. Multifunctional Ca2+/calmodulin-dependent protein kinase. Neurochem Res 1993;18:65-77.
119. Colbran RJ. Targeting of calcium/calmodulin-dependent protein kinase II. Biochem J 2004;378:1-16.
120. Schworer CM, Colbran RJ, Soderling TR. Reversible generation of a Ca2+-independent form of Ca2+ (calmodulin)-dependent protein kinase II by an autophosphorylation mechanism. J Biol Chem 1986;261:8581-584.
121. Lai Y, Nairn AC, Greengard P. Autophosphorylation reversibly regulates the Ca2+/calmod-ulin-dependence of Ca2+/calmodulin-dependent protein kinase II. Proc Natl Acad Sci USA 1986;83:4253-4257.
122. Sandal T, Ahlgren R, Lillehaug J, Doskeland SO. Establishment of okadaic acid resistant cell clones using a cDNA expression library. Cell Death Differ 2001;8:754-766.
123. Sandal T, Aumo L, Hedin L, Gjertsen BT, Doskeland SO. Irod/Ian5: an inhibitor of gamma-radiation-and okadaic acid-induced apoptosis. Mol Biol Cell 2003;14:3292-3304.
124. Hornum L, Romer J, Markholst H. The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. Diabetes 2002;51:1972-1979.
125. MacMurray AJ, Moralejo DH, Kwitek AE, et al. Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res 2002;12:1029-1039.
126. Ding WX, Nam Ong C. Role of oxidative stress and mitochondrial changes in cyanobacteria-induced apoptosis and hepatotoxicity. FEMS Microbiol Lett 2003;220:1-7.
127. Ding WX, Shen HM, Ong CN. Critical role of reactive oxygen species and mitochondrial permeability transition in microcystin-induced rapid apoptosis in rat hepatocytes. Hepatology 2000;32:547-555.
128. Howe CJ, Lahair MM, McCubrey JA, Franklin RA. Redox Regulation of the Calcium/Calmodulin-dependent Protein Kinases. J Biol Chem 2004;279:44, 573-44, 581.
129. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996; 14:33-38, 27-28.